Brennan-Speranza Tara C, Mor David, Mason Rebecca S, Bartlett John R, Duque Gustavo, Levinger Itamar, Levinger Pazit
Department of Physiology and Bosch Institute for Medical Research, University of Sydney, Sydney, Australia.
Discipline of Biomedical Sciences and Bosch Institute for Medical Research, University of Sydney, Sydney, Australia.
J Steroid Biochem Mol Biol. 2017 Oct;173:180-184. doi: 10.1016/j.jsbmb.2017.01.022. Epub 2017 Feb 1.
Muscle function is often impaired in patients with knee osteoarthritis (OA), with reduced strength and increased pain. The role of vitamin D and the vitamin D-endocrine pathway in muscle health has recently been placed in the spotlight, with various groups reporting positive effects on muscle development, function and health. Recently, it has been shown that uptake into muscle of the specialized vitamin D binding protein (DBP) is dependent on the endocytic receptor, megalin. Here we analyse circulating vitamin D, and muscle DBP, megalin and the cognate vitamin D receptor (VDR) in patients with knee OA and compare them to asymptomatic controls. Muscle and blood samples were collected from 19 patients with end-stage OA of the knee and 10 age-matched controls. Muscle biopsies from the OA group were performed during knee replacement surgery and a needle biopsy was used on control volunteers. Immunoblots performed with specific antibodies were used to detect the presence of DBP, megalin, VDR (using the specific D-6 antibody) and albumin in the muscle biopsies. Results were correlated with FoxO1, a key regulator of the ubiquitin-proteasome degradation pathway in muscle. There were no differences in circulating levels of 25 (OH) vitamin D3 between the groups, and no subjects were vitamin D deficient. We found increased VDR, DBP and albumin protein in the muscle from patients with OA compared to controls, with no change in muscle megalin expression. Furthermore, DBP levels in the muscle correlated with FoxO1, suggesting an association between muscle protein breakdown and the activation of the vitamin D-endocrine pathway in muscle surrounding an OA affected joint. We show, for the first time, that the factors involved in the vitamin D-endocrine-pathway are present at higher levels in muscles from OA patients compared to asymptomatic controls. This is despite no differences in circulating 25 (OH) vitamin D levels between the groups. These findings indicate the activation of vitamin D pathway in these muscles that may provide a beneficial compensatory stimulation of the repair process in muscles that are subject to inflammatory and proteolytic processes.
膝关节骨关节炎(OA)患者的肌肉功能常常受损,表现为力量减弱和疼痛加剧。维生素D及维生素D内分泌途径在肌肉健康中的作用最近备受关注,多个研究团队报告了其对肌肉发育、功能和健康的积极影响。最近有研究表明,特殊维生素D结合蛋白(DBP)进入肌肉依赖于内吞受体巨膜蛋白。在此,我们分析了膝关节OA患者的循环维生素D、肌肉DBP、巨膜蛋白及相关维生素D受体(VDR),并将其与无症状对照组进行比较。我们从19例终末期膝关节OA患者和10例年龄匹配的对照组中采集了肌肉和血液样本。OA组的肌肉活检在膝关节置换手术期间进行,对照组志愿者则采用针吸活检。使用特异性抗体进行免疫印迹,以检测肌肉活检样本中DBP、巨膜蛋白、VDR(使用特异性D-6抗体)和白蛋白的存在情况。结果与肌肉中泛素-蛋白酶体降解途径的关键调节因子FoxO1相关。两组之间25(OH)维生素D3的循环水平没有差异,且没有受试者维生素D缺乏。我们发现,与对照组相比,OA患者肌肉中的VDR、DBP和白蛋白蛋白增加,而肌肉巨膜蛋白表达没有变化。此外,肌肉中的DBP水平与FoxO1相关,提示OA受累关节周围肌肉中的蛋白质分解与维生素D内分泌途径的激活之间存在关联。我们首次表明,与无症状对照组相比,OA患者肌肉中参与维生素D内分泌途径的因子水平更高。尽管两组之间循环25(OH)维生素D水平没有差异。这些发现表明这些肌肉中维生素D途径的激活,可能为遭受炎症和蛋白水解过程的肌肉修复过程提供有益的代偿性刺激。